IL142762A0 - Compositions comprising cefuroxime axetil - Google Patents
Compositions comprising cefuroxime axetilInfo
- Publication number
- IL142762A0 IL142762A0 IL14276299A IL14276299A IL142762A0 IL 142762 A0 IL142762 A0 IL 142762A0 IL 14276299 A IL14276299 A IL 14276299A IL 14276299 A IL14276299 A IL 14276299A IL 142762 A0 IL142762 A0 IL 142762A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- cefuroxime axetil
- axetil
- cefuroxime
- Prior art date
Links
- KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 title 1
- 229960002620 cefuroxime axetil Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0198998A AT413647B (de) | 1998-11-26 | 1998-11-26 | Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten |
| PCT/EP1999/009096 WO2000030647A1 (en) | 1998-11-26 | 1999-11-24 | Compositions comprising cefuroxime axetil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142762A0 true IL142762A0 (en) | 2002-03-10 |
Family
ID=3525440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14276299A IL142762A0 (en) | 1998-11-26 | 1999-11-24 | Compositions comprising cefuroxime axetil |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6727243B1 (de) |
| EP (1) | EP1133298B1 (de) |
| JP (1) | JP2002530338A (de) |
| KR (1) | KR20010080566A (de) |
| CN (1) | CN1330546A (de) |
| AR (1) | AR021405A1 (de) |
| AT (3) | AT413647B (de) |
| AU (1) | AU759517B2 (de) |
| BR (1) | BR9915694A (de) |
| CA (1) | CA2348876A1 (de) |
| CO (1) | CO5190668A1 (de) |
| CZ (1) | CZ20011845A3 (de) |
| DE (1) | DE69935609T2 (de) |
| ES (1) | ES2285866T3 (de) |
| HU (1) | HUP0104412A3 (de) |
| ID (1) | ID28615A (de) |
| IL (1) | IL142762A0 (de) |
| MY (1) | MY129564A (de) |
| NO (1) | NO20012526L (de) |
| NZ (1) | NZ511588A (de) |
| PE (1) | PE20001326A1 (de) |
| PL (1) | PL348744A1 (de) |
| RU (1) | RU2248794C2 (de) |
| SI (1) | SI1133298T1 (de) |
| SK (1) | SK7162001A3 (de) |
| TR (1) | TR200101417T2 (de) |
| TW (1) | TWI229603B (de) |
| WO (1) | WO2000030647A1 (de) |
| YU (1) | YU34601A (de) |
| ZA (1) | ZA200103927B (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100342943B1 (ko) * | 1999-08-04 | 2002-07-02 | 민경윤 | 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물 |
| US7527807B2 (en) * | 2000-06-21 | 2009-05-05 | Cubist Pharmaceuticals, Inc. | Compositions and methods for increasing the oral absorption of antimicrobials |
| AU2001230490A1 (en) * | 2000-12-01 | 2002-06-11 | Arun Shriniwas Gosavi | Pharmaceutical formulation |
| EP1911462A3 (de) * | 2001-01-26 | 2011-11-30 | Schering Corporation | Zusammensetzungen enthaltend einen Sterolabsorptionshemmer |
| US6524617B1 (en) * | 2001-07-25 | 2003-02-25 | Isp Investments Inc. | Synergistic filler composition |
| MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
| ES2201932B2 (es) * | 2001-11-23 | 2005-03-16 | Glaxo Group Limited | Composicion farmaceutica. |
| TW200404550A (en) * | 2002-07-08 | 2004-04-01 | Sankyo Co | Cepharospolin formulation for oral use |
| JP4526247B2 (ja) * | 2002-07-08 | 2010-08-18 | 第一三共株式会社 | 経口用セファロスポリン製剤 |
| AU2003260803A1 (en) * | 2002-08-30 | 2004-03-19 | Orchid Chemicals And Pharmaceuticals Ltd. | Sustained release pharmaceutical composition |
| WO2005002540A2 (en) * | 2003-07-01 | 2005-01-13 | Ranbaxy Laboratories Limited | Dry powder pharmaceutical suspension compositions of cefuroxime axetil |
| KR100552567B1 (ko) * | 2003-08-23 | 2006-02-15 | 한국유나이티드제약 주식회사 | 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법 |
| AU2006242535B2 (en) * | 2005-04-29 | 2012-08-09 | Merck Sharp & Dohme Corp. | Therapeutic compositions |
| CN100402035C (zh) * | 2005-07-07 | 2008-07-16 | 石药集团中奇制药技术（石家庄）有限公司 | 一种微囊化头孢呋辛酯的药物组合物 |
| EP2579860B1 (de) | 2010-06-14 | 2014-04-23 | Ratiopharm GmbH | Ivabradinhaltige pharmazeutische zusammensetzung mit modifizierter freisetzung |
| EP2882423A1 (de) * | 2012-08-07 | 2015-06-17 | Sandoz AG | Unbeschichtete tablette mit granulat mit einem beta-lactam-antibiotikum und stark dispergiertem silikondioxid |
| US9603804B2 (en) | 2013-04-25 | 2017-03-28 | Kyorin Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
| CA2910121A1 (en) | 2013-04-25 | 2014-10-30 | Kyorin Pharmaceutical Co., Ltd. | A pharmaceutical composition comprising a 1,4-dihydroquinoline carboxylic acid a cellulosic excipient and a salting-out agent |
| CA2965473A1 (en) | 2014-10-23 | 2016-04-28 | Kyorin-Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572993A (en) * | 1976-02-16 | 1980-08-13 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
| GB1571683A (en) * | 1976-02-16 | 1980-07-16 | Glaxo Operations Ltd | Ester derivatives of cefuroxime |
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| GB8524001D0 (en) * | 1985-09-30 | 1985-11-06 | Glaxo Group Ltd | Pharmaceutical composition |
| ZA881301B (en) * | 1987-02-27 | 1989-10-25 | Lilly Co Eli | Sustained release matrix formulations |
| NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
| DE3810343A1 (de) * | 1988-03-26 | 1989-10-05 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen retardformen |
| DE4139963A1 (de) * | 1991-12-04 | 1993-06-09 | Basf Ag, 6700 Ludwigshafen, De | Redispergierbares dispersionspulver aus n-vinylpyrrolidon-vinylacetat-copolymerisat, dessen herstellung und verwendung |
| DE19602757A1 (de) * | 1996-01-26 | 1997-07-31 | Boehringer Mannheim Gmbh | Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung |
| US5663258A (en) * | 1996-02-20 | 1997-09-02 | Isp Investments Inc. | Strongly swellable, moderately crosslinked copolymers of vinylpyrrolidone and vinyl acetate |
| DE19631085A1 (de) * | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut |
| US6190591B1 (en) * | 1996-10-28 | 2001-02-20 | General Mills, Inc. | Embedding and encapsulation of controlled release particles |
| IL119627A (en) * | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
| CA2209868C (en) * | 1997-08-15 | 2001-08-14 | Bernard Charles Sherman | Pharmaceutical compositions comprising cefuroxime axetil |
| JP2002505290A (ja) | 1998-03-03 | 2002-02-19 | ダエウン ファーマシューティカル カンパニー リミテッド | 水分吸収に対して安定であるセフロキシムアクセチルを含む医薬組成物 |
| CA2239331C (en) * | 1998-05-29 | 1999-11-30 | Bernard Charles Sherman | Pharmaceutical tablets comprising cefuroxime axetil |
| DE19835823A1 (de) * | 1998-08-10 | 1999-10-07 | Lindopharm Gmbh | Pharmazeutische Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung sowie aus ihr hergestellte wässerige Suspension |
| KR100342943B1 (ko) | 1999-08-04 | 2002-07-02 | 민경윤 | 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물 |
-
1998
- 1998-11-26 AT AT0198998A patent/AT413647B/de not_active IP Right Cessation
-
1999
- 1999-11-20 TW TW088120315A patent/TWI229603B/zh not_active IP Right Cessation
- 1999-11-24 EP EP99959327A patent/EP1133298B1/de not_active Expired - Lifetime
- 1999-11-24 IL IL14276299A patent/IL142762A0/xx unknown
- 1999-11-24 CN CN99813759A patent/CN1330546A/zh active Pending
- 1999-11-24 AT AT99959327T patent/ATE357237T1/de active
- 1999-11-24 YU YU34601A patent/YU34601A/sh unknown
- 1999-11-24 BR BR9915694-6A patent/BR9915694A/pt not_active IP Right Cessation
- 1999-11-24 KR KR1020017006542A patent/KR20010080566A/ko not_active Application Discontinuation
- 1999-11-24 HU HU0104412A patent/HUP0104412A3/hu unknown
- 1999-11-24 DE DE69935609T patent/DE69935609T2/de not_active Expired - Lifetime
- 1999-11-24 SI SI9930969T patent/SI1133298T1/sl unknown
- 1999-11-24 TR TR2001/01417T patent/TR200101417T2/xx unknown
- 1999-11-24 AU AU16544/00A patent/AU759517B2/en not_active Ceased
- 1999-11-24 PL PL99348744A patent/PL348744A1/xx unknown
- 1999-11-24 US US09/445,741 patent/US6727243B1/en not_active Expired - Fee Related
- 1999-11-24 WO PCT/EP1999/009096 patent/WO2000030647A1/en active IP Right Grant
- 1999-11-24 SK SK716-2001A patent/SK7162001A3/sk unknown
- 1999-11-24 NZ NZ511588A patent/NZ511588A/en unknown
- 1999-11-24 CA CA002348876A patent/CA2348876A1/en not_active Abandoned
- 1999-11-24 RU RU2001117518/15A patent/RU2248794C2/ru not_active IP Right Cessation
- 1999-11-24 JP JP2000583530A patent/JP2002530338A/ja not_active Withdrawn
- 1999-11-24 ES ES99959327T patent/ES2285866T3/es not_active Expired - Lifetime
- 1999-11-24 ID IDW00200101088A patent/ID28615A/id unknown
- 1999-11-24 CZ CZ20011845A patent/CZ20011845A3/cs unknown
- 1999-11-25 PE PE1999001186A patent/PE20001326A1/es not_active Application Discontinuation
- 1999-11-25 AR ARP990106024A patent/AR021405A1/es not_active Application Discontinuation
- 1999-11-26 MY MYPI99005158A patent/MY129564A/en unknown
- 1999-11-26 CO CO99074648A patent/CO5190668A1/es not_active Application Discontinuation
-
2001
- 2001-05-15 ZA ZA200103927A patent/ZA200103927B/en unknown
- 2001-05-23 NO NO20012526A patent/NO20012526L/no not_active Application Discontinuation
-
2004
- 2004-02-23 AT AT0028104A patent/AT500135A1/de not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL137550A0 (en) | Epothilone compositions | |
| AP2000001874A0 (en) | Cellecoxib compositions | |
| GB9917982D0 (en) | Compositions | |
| PL330949A1 (en) | Antibacterial compositions | |
| GB9811377D0 (en) | Compositions | |
| GB9924268D0 (en) | Compositions | |
| IL142762A0 (en) | Compositions comprising cefuroxime axetil | |
| GB9828861D0 (en) | Compositions | |
| PL341815A1 (en) | Novel naphtyl- and anilide-susbtituted sulphonamides | |
| IL139733A0 (en) | Novel compositions | |
| GB2339693B (en) | Anti-mollusc compositions | |
| GB9905325D0 (en) | Compositions | |
| GB9806810D0 (en) | Compositions | |
| GB0016470D0 (en) | Compositions | |
| GB9827291D0 (en) | Compositions | |
| GB9812818D0 (en) | Dentfrice compositions | |
| GB2336535B (en) | Compositions | |
| GB9809347D0 (en) | Compositions | |
| AU2178900A (en) | Cleaning compositions | |
| GB9816050D0 (en) | Compositions | |
| GB9827690D0 (en) | Compositions | |
| AU6271499A (en) | Cleaning compositions | |
| GB9818278D0 (en) | Compositions | |
| GB9809121D0 (en) | Novel compositions | |
| GB9816423D0 (en) | Novel compositions |